• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌谷氨酸消旋酶抑制剂的先导化合物鉴定与优化。

Lead identification and optimization of bacterial glutamate racemase inhibitors.

作者信息

Malapati Prasanthi, Siva Krishna Vagolu, Nallangi Radhika, Meda Nikhila, Reshma Srilakshmi Rudraraju, Sriram Dharmarajan

机构信息

Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Jawahar Nagar, Hyderabad 500078, India.

Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Jawahar Nagar, Hyderabad 500078, India.

出版信息

Bioorg Med Chem. 2018 Jan 1;26(1):177-190. doi: 10.1016/j.bmc.2017.11.031. Epub 2017 Nov 21.

DOI:10.1016/j.bmc.2017.11.031
PMID:29239770
Abstract

Mycobacterium tuberculosis glutamate racemase is an essential enzyme involved in peptidoglycan synthesis and conserved in most bacteria. Small molecule inhibitors were reported on other bacterial species whereas in M. tuberculosis it wasn't explored much. In this study we have screened in house compound library using fluorescence thermal shift assay and enzyme inhibition assay, form this (1-(3-(benzo[d]thiazol-2-yl)phenyl)-3-(p-tolyl)thiourea) was identified as lead compound with IC 19.47 ± 0.81 μM. Further lead optimization by synthesis resulted in twenty-three compounds, of which Compound 25 has shown more efficacy compared to lead 1 showing non-competitive mode of inhibition with IC 1.32 ± 0.43 μM. It also showed significant activity (represented in log reduction) in nutrient starved dormant M. tuberculosis model (2.1), M. tuberculosis biofilm assay (2.0) and in vivo M. marinum infected zebrafish model (3.5).

摘要

结核分枝杆菌谷氨酸消旋酶是一种参与肽聚糖合成的必需酶,在大多数细菌中保守存在。其他细菌物种已有小分子抑制剂的报道,而在结核分枝杆菌中对此研究较少。在本研究中,我们使用荧光热位移测定法和酶抑制测定法筛选了内部化合物库,从中鉴定出(1-(3-(苯并[d]噻唑-2-基)苯基)-3-(对甲苯基)硫脲)作为先导化合物,其IC为19.47±0.81μM。通过合成进行进一步的先导优化产生了23种化合物,其中化合物25与先导化合物1相比显示出更高的效力,表现出非竞争性抑制模式,IC为1.32±0.43μM。它在营养饥饿的休眠结核分枝杆菌模型(2.1)、结核分枝杆菌生物膜测定(2.0)和体内海鱼分枝杆菌感染的斑马鱼模型(3.5)中也显示出显著活性(以对数减少表示)。

相似文献

1
Lead identification and optimization of bacterial glutamate racemase inhibitors.细菌谷氨酸消旋酶抑制剂的先导化合物鉴定与优化。
Bioorg Med Chem. 2018 Jan 1;26(1):177-190. doi: 10.1016/j.bmc.2017.11.031. Epub 2017 Nov 21.
2
Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors.鉴定和开发苯并恶唑衍生物作为新型细菌谷氨酸消旋酶抑制剂。
Eur J Med Chem. 2018 Feb 10;145:23-34. doi: 10.1016/j.ejmech.2017.12.088. Epub 2017 Dec 30.
3
Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.新型赖氨酸ε-氨基转移酶抑制剂的发现:潜伏性结核病的一个引人关注的潜在靶点。
Tuberculosis (Edinb). 2015 Dec;95(6):786-794. doi: 10.1016/j.tube.2015.04.010. Epub 2015 Aug 8.
4
Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis.谷氨酸消旋酶是结核分枝杆菌中β-氯-d-丙氨酸的主要作用靶点。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6091-9. doi: 10.1128/AAC.01249-16. Print 2016 Oct.
5
Identification and development of novel indazole derivatives as potent bacterial peptidoglycan synthesis inhibitors.新型吲唑衍生物作为强效细菌肽聚糖合成抑制剂的鉴定与开发
Int J Mycobacteriol. 2018 Jan-Mar;7(1):76-83. doi: 10.4103/ijmy.ijmy_201_17.
6
Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.基于硫脲的衍生物的设计与合成作为结核分枝杆菌生长和烯酰基辅酶 A 还原酶(InhA)抑制剂。
Eur J Med Chem. 2020 Aug 1;199:112402. doi: 10.1016/j.ejmech.2020.112402. Epub 2020 May 4.
7
Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis-an enzyme involved in peptidoglycan biosynthesis.乙胺丁醇靶向结核分枝杆菌的谷氨酸消旋酶——一种参与肽聚糖生物合成的酶。
Appl Microbiol Biotechnol. 2019 Jan;103(2):843-851. doi: 10.1007/s00253-018-9518-z. Epub 2018 Nov 19.
8
High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.高通量筛选鉴定出靶向结核分枝杆菌GlmU乙酰转移酶活性的小分子抑制剂。
Tuberculosis (Edinb). 2015 Dec;95(6):664-677. doi: 10.1016/j.tube.2015.06.003. Epub 2015 Jul 31.
9
Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis.5,6,7,8-四氢苯并[4,5]噻吩并[2,3-d]嘧啶-4-胺类似物对非复制型结核分枝杆菌具有高活性的抗结核活性。
Bioorg Med Chem. 2016 Nov 1;24(21):5556-5564. doi: 10.1016/j.bmc.2016.09.012. Epub 2016 Sep 9.
10
Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.鉴定一种新型异柠檬酸裂解酶抑制剂作为针对活性和非复制性结核分枝杆菌的强效抗结核药物。
Tuberculosis (Edinb). 2016 Mar;97:38-46. doi: 10.1016/j.tube.2015.12.003. Epub 2016 Jan 6.

引用本文的文献

1
Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery.硫脲衍生物的分枝杆菌靶标:结核病药物发现中的虚拟筛选机会。
Curr Med Chem. 2024;31(29):4703-4724. doi: 10.2174/0109298673276076231124104513.
2
Synthesis and identification of new sacubitril derivatives as lead compounds for antibacterial, antifungal and antitubercular (TB) activities against dormant tuberculosis.新型沙库巴曲衍生物的合成与鉴定:作为针对潜伏性结核的抗菌、抗真菌和抗结核(TB)活性的先导化合物
RSC Adv. 2023 May 3;13(20):13540-13546. doi: 10.1039/d3ra00713h. eCollection 2023 May 2.
3
Racemases and epimerases operating through a 1,1-proton transfer mechanism: reactivity, mechanism and inhibition.
通过 1,1-质子转移机制作用的外消旋酶和差向异构酶:反应性、机制和抑制。
Chem Soc Rev. 2021 May 24;50(10):5952-5984. doi: 10.1039/d0cs00540a.
4
Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids.筛选靶向结核分枝杆菌谷氨酸 racemase 的天然化合物,揭示了黄酮类化合物的抗结核潜力。
Sci Rep. 2020 Jan 22;10(1):949. doi: 10.1038/s41598-020-57658-8.
5
Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads.发现和评估新型结核分枝杆菌酮酸还原异构酶抑制剂作为治疗药物先导物。
J Comput Aided Mol Des. 2019 Mar;33(3):357-366. doi: 10.1007/s10822-019-00184-1. Epub 2019 Jan 21.